6 results
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... Species: • Mycobacterium ... Mycobacterium africanum ... • Mycobacterium ... inhibitors • Injection drug
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
RIPE Therapy - Drug ... - IDSA Guidelines ... #Tuberculosis ... #ActiveTB #RIPE ... #medications #pharmacology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... Species: • Mycobacterium ... Mycobacterium africanum ... • Mycobacterium ... inhibitors • Injection drug
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... for Treating Mycobacterium ... Tuberculosis Infection ... latent TB • Close ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
IDSA Recommendations ... Treating Disseminated Mycobacterium ... Note: Active TB ... AviumComplex #MAC #IDSA ... infections #HIVAIDS #pharmacology
Chloramphenicol - Antibiotics Class Overview

– 50S ribosomal inhibitor.   IV or PO (but PO form
Antibiotics Class Overview ... beta-lactam allergy (has activity ... beta-lactam allergy would ... several weeks after drug ... #Pharmacology #Antibiotics